Abantu bathatha izithako ze-chondroitin sulfate ngokuvamile ukusiza ukuphatha i-osteoarthritis, isifo esivamile samathambo esithinta uqwanga oluzungezile amalunga akho.
Abasekeli bathi uma kuthathwa njengesengezo, kwandisa ukuhlanganiswa kwezingxenye ezihlukahlukene ze-cartilage ngenkathi futhi kuvimbele ukuwohloka kwe-cartilage (4Trusted Source).
Ukubuyekezwa kwe-2018 yezifundo ze-26 kubonise ukuthi ukuthatha izithako ze-chondroitin kungase kuthuthukise izimpawu zobuhlungu nokusebenza okuhlangene uma kuqhathaniswa nokuthatha indawo ye-placebo (5Trusted Source).
Ukubuyekezwa kwango-2020 kuphakamisa ukuthi kungase kubambezele ukuqhubeka kwe-OA, kuyilapho kuphinde kwehlise nesidingo sezidakamizwa ezilwa nokuvuvukala, njenge-ibuprofen, eza nemiphumela yazo engemihle (6).
Ngakolunye uhlangothi, izifundo ezimbalwa azitholanga ubufakazi obanele bokuphakamisa ukuthi i-chondroitin ingasiza ekudambiseni izimpawu ze-OA, okuhlanganisa ukuqina kwamalunga noma ubuhlungu (7Trusted Source, 8Trusted Source, 9Trusted Source).
Ama-ejensi amaningana angochwepheshe, njenge-Osteoarthritis Research Society International kanye ne-American College of Rheumatology, abakhuthazi abantu ukusebenzisa i-chondroitin ngenxa yobufakazi obuxubile bokusebenza kwayo (10Trusted Source, 11Trusted Source).
Nakuba izithako ze-chondroitin zingase zibhekane nezimpawu ze-OA, azihlinzeki ngokwelapha unomphela.
Isikhathi sokuthumela: Aug-13-2022